ArticleCureus2026
Miescher's Granulomatous Cheilitis: A Rare Cause of Recurrent Lip Inflammation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Miescher's granulomatous cheilitis (GC) is a rare, noninfectious, chronic, idiopathic granulomatous disorder characterized by recurrent swelling of the lips. It is considered part of the triad of Melkersson-Rosenthal syndrome, a neurological and cutaneous disorder characterized by orofacial edema, peripheral facial nerve palsy, and a fissured tongue. However, the complete triad is uncommon, and Miescher's GC may present as a monosymptomatic form. Due to its rarity, the condition has a broad differential diagnosis and poses a diagnostic challenge. We report the case of a 33-year-old woman with no relevant medical history who presented with chronic, recurrent swelling of the lower lip. She was initially treated for a presumed allergic reaction with antihistamines, without improvement. A lip biopsy was performed, revealing histopathological findings consistent with GC. The patient was treated with prednisone and doxycycline, followed by intralesional methylprednisolone injections, resulting in a favorable clinical response without recurrence. This case highlights the importance of recognizing localized orofacial manifestations and providing timely, individualized treatment to reduce the risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.